3rd Annual Symposium

Glom-NExT3
3rd Annual Glom-NExT Symposium


Tuesday, April 4, 2017
Broad Institute
Cambridge, MA

 

A call to action for the discovery of
new treatments for kidney diseases

 

 

Register Online to Attend

 


SYMPOSIUM PROGRAM

 

9:00 AM

 

Welcome
Anna Greka

SESSION 1


Human genetics and the search for validated therapeutic targets
Chairs: Martin Pollak and Friedhelm Hildebrandt

 

9:10 - 9:40 AM


Extracting useful information from large genomic datasets
Daniel MacArthur

 

9:40 - 10:10 AM


Genomics of nephrotic syndrome
Matt Sampson

 

10:10 - 10:40 AM

APOL1 as a therapeutic target
Katalin Suzstak

 

10:40 - 11:00 AM


 Coffee Break

SESSION 2


Keynote Address

Chair: Joseph Bonventre

 

11:00 - 12:00 PM


Genetic components of common human diseases
Nancy Cox

 

 

12:00 - 12:40 PM

 

Lunch
SESSION 3


Towards precision medicines for kidney diseases

Chairs: Alda Tufro and Ed Skolnik

12:40 - 1:10 PM


Kidney on a chip
Jonathan Himmelfarb

1:10 - 1:40 PM
Precision medicines for genetically defined kidney diseases
Peter Mundel

1:40 - 2:00 PM


Coffee Break

 SESSION 4


The many facets of drug development
Chairs: Jeffrey Kopp and Reshma Kewalramani

 2:00 - 2:30 PM


The biopharma perspective: Louis Brenner

 2:30 - 3:00 PM


The FDA perspective: Aliza Thompson

 3:00 - 3:30 PM


The patient perspective: Kevin Fowler

 

 SESSION 5

 

Roundtable discussion and brainstorming session: 
How can we do better?

 

 3:30 - 4:50 PM

 

Speakers: Mark Okusa, Abbie Celnicker, Terry Watnick, Kathleen Broderick
In this brainstorming session, we will discuss how we can enhance current efforts to impact on novel therapeutics for kidney disease

 

 4:50 PM


Closing remarks

Anna Greka